For years, much of the conversation around cannabis quality has focused on what goes into the product: potency, pesticides, solvents, microbial contamination, terpene profiles, and certificates of analysis. That scrutiny is necessary, but it stops one step too soon. Cannabis is burned in a pipe, heated inside a vaporizer cartridge, exposed to a high-temperature surface…
Continue reading →
Brought to you by Cannabis Industry Journal, the 2026 Cannabis Quality Conference (CQC) is a business-to-business conference and expo where cannabis industry leaders and stakeholders meet to build the future of the cannabis marketplace. In a location surrounded by new market opportunities, the CQC will deliver hands-on education, networking and business discussions. The Agenda focuses on Quality Management, Shifting from Reactive to Proactive Decision-Making through Quality Management, Regulations and Standards, Testing & Analysis, Technology and Data Solutions., and Audits and Supplier Management. The venue setting, coupled with our highly focused content, creates a business meeting environment unlike anything else. The 2026 Cannabis Quality Conference (CQC) co-located with the Food Safety Consortium Conference, October 21-23, 2026 in Washington DC, at the Crystal Gateway Marriott, Arlington VA directly across the Potomac River from Washington, DC. The Program includes workshops and training as part of the 2.5 days of high-level panel discussions and educational presentations.
Continue reading →
Betty’s Eddies reveals a new twist on gummies
Continue reading →
Setting the stage for the future of healthcare
Continue reading →
As cannabinoids move into healthcare and medical applications, suppliers must deliver more than potency, purity, and a certificate of analysis.
Continue reading →
MMJ Holdings Throws Its Weight Into the Legal Fight
Continue reading →
As extraction technologies improve and stabilization techniques advance, acidic cannabinoids may represent one of the most promising frontiers in cannabis product innovation.
Continue reading →
A Look at the Bloomwell Group’s German Business Model
Continue reading →
Cannabis medicine is about to move beyond today’s trial-and-error approach toward more personalized, precise treatments
Continue reading →
Strategy, Scale, and Survival in a Maturing Adult-Use Market
Continue reading →